10 How Cloud ERP Software Can Help Manufacturers Succeed Post-Brexit
The repercussions of events like Brexit and the global pandemic have caused uncertainty and a need to rethink strategy altogether. However, an integrated SaaS solution can provide a holistic view of the business and enhanced control over processes.
14 Plant-Powered Formulations Offer a Sustainable Future
Innovative oral therapeutics that meet patients’ needs for ease of use and the desire for more environmentally friendly solutions, have the best chance of success.
16 Predictive Digital Twins Help Pharmaceutical Companies Plan
In an uncertain environment, using technologies like digital twins and predictive simulation can help forecast the impact of changes across the manufacturing process without affecting current business practices.
18 How API Manufacturers and Technology Suppliers Can Mitigate Potent API Processing Risks
Companies are striving to build safety, quality, and efficiency into their potent API processes, but there are challenges to be faced on that journey to ensure these hazardous compounds are handled properly.
21 Improving Systems Integration in Manufacturing
Pharma has been slow to adopt new technology in its manufacturing plants, partly because it fears change and partly because it often has a mix of legacy equipment. However, embracing greater interoperability through technology can smooth processes and support data integrity.
24 The Changing Face of Quality Management
Smart automation is enabling new ways to monitor and intervene pre-emptively in pharma manufacturing. Find out the views of industry experts, who debated the subject in a roundtable video discussion.
27 Advances in In-Line Rheology Measurement of Topical Pharmaceuticals
Many elements make up the composition of topical pharmaceutical products, and maintaining the correct rheological characteristics is vital to avoid product quality and even failure.
30 A Roadmap to Effective Digital Transformation
Outdated, siloed, and inconsistent data infrastructures are hampering advances in pharmaceutical manufacturing. By adopting the ‘simplify, optimise, automate, outsource’ method, a foundation of optimised processes can be built to reduce complexity.
34 Transforming Patient Data Automation for Clinical Trials
Manual duplication of records is time-consuming and risks errors. New technology, that works with all systems, promises to eliminate these challenges and improve data integrity.
38 Powering Clinical Trial Analytics With Automation
Using end-to-end technology across the clinical trial process, married with updated quality standards, will accelerate the review and usability of data, thereby reducing time to market for new therapies.
41 ‘Storming and Forming’ Cloud Deployment
Pharma companies are starting to understand the benefits of digitalisation and cloud storage, moving from merely gathering data to exploiting it for competitive advantage.
44 Microbiomes and the New Bio Revolution
The potential for microbiomes to transform drug development and improve health and wellbeing is huge. Data science will help to unlock its promise and accelerate the new bio revolution.
6 Editorial Desk
editorial team attempts to navigate the latest pharmaceutical innovations in a time of devastation in Ukraine and around the world.
8 Industry News
Discover some of the latest innovations and products from the biggest companies in the pharma industry.
In-person exhibitions are back for 2022. Take a look at what’s in store for the next quarter in pharma.
Index of Advertisers
Connect to Pharma
Natoli Engineering Company Inc.
PMGroup Worldwide Ltd
EDITORIAL AND PRODUCTION ASSISTANT
Fishman64 – Shutterstock.com
Tel: +44 (0)20 7724 3456
Fax: +44 (0)20 7403 7747
Hardings Print Solutions
SUBSCRIPTIONS AND DATA
Curwood CMS Ltd
Unit 9 Barns & Stables, Timworth Green,
Tel: 01580 883841
Innovations in Pharmaceutical Technology (ISSN: 1471-7204, USPS No: 025082) is published four times a year – March, June, September, and December – by Samedan Ltd.
The opinions and views expressed by the authors in this book are not necessarily those of the Editor the Publisher and, while every care has been taken in the preparation of the book, the Editor and the Publisher are not responsible for such opinions and views or for
any inaccuracies in the articles.
The Publisher is not responsible for any images supplied by contributors. While every care is taken with artwork supplied, the Publisher cannot be held responsible for any loss or damage incurred.
The entire content of this publication is protected by copyright. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form, by any means – electronic,
mechanical, photocopying, or otherwise – without the prior permission of the Publisher.
© 2022 Samedan Ltd
Be sure to read our other publications...